Overview

Cholinergic Modulation of Condition and Emotion in Mood Disorders: Functional Neuroimaging Studies

Status:
Terminated
Trial end date:
2015-02-02
Target enrollment:
Participant gender:
Summary
This study looks at the role of a specific brain chemical system in the mood and attention symptoms seen in major depression and bipolar disorders using functional brain imaging.
Phase:
Phase 2
Details
Lead Sponsor:
National Institute of Mental Health (NIMH)
Treatments:
Butylscopolammonium Bromide
Cholinergic Agents
Scopolamine
Scopolamine Hydrobromide